STAAR Surgical Company
STAA · NASDAQ
12/27/2024 | 12/29/2023 | 12/30/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $314 | $322 | $284 | $230 |
| % Growth | -2.6% | 13.4% | 23.4% | – |
| Cost of Goods Sold | $74 | $70 | $61 | $52 |
| Gross Profit | $240 | $253 | $223 | $179 |
| % Margin | 76.3% | 78.4% | 78.5% | 77.5% |
| R&D Expenses | $54 | $44 | $36 | $34 |
| G&A Expenses | $90 | $72 | $55 | $44 |
| SG&A Expenses | $198 | $180 | $144 | $111 |
| Sales & Mktg Exp. | $108 | $108 | $89 | $67 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $252 | $225 | $180 | $145 |
| Operating Income | -$13 | $28 | $44 | $33 |
| % Margin | -4% | 8.7% | 15.4% | 14.5% |
| Other Income/Exp. Net | $4 | $6 | $2 | -$2 |
| Pre-Tax Income | -$9 | $34 | $46 | $31 |
| Tax Expense | $11 | $12 | $6 | $4 |
| Net Income | -$20 | $21 | $40 | $28 |
| % Margin | -6.4% | 6.6% | 13.9% | 11.9% |
| EPS | -0.41 | 0.44 | 0.83 | 0.52 |
| % Growth | -193.2% | -47% | 59.6% | – |
| EPS Diluted | -0.41 | 0.43 | 0.8 | 0.5 |
| Weighted Avg Shares Out | 49 | 49 | 48 | 47 |
| Weighted Avg Shares Out Dil | 49 | 49 | 49 | 49 |
| Supplemental Information | – | – | – | – |
| Interest Income | $6 | $7 | $2 | – |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $7 | $5 | $5 | $4 |
| EBITDA | -$6 | $33 | $48 | $37 |
| % Margin | -1.8% | 10.3% | 17% | 16% |